adenine has been researched along with Graves Disease in 6 studies
Graves Disease: A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy).
| Excerpt | Relevance | Reference |
|---|---|---|
| "We studied 27 patients with untreated Graves' disease, 10 with Graves' disease complicated by ophthalmopathy (all on antithyroid medication), 11 with Hashimoto's thyroiditis, five with multinodular goitre, one with thyroid carcinoma, 23 with type 1 diabetes mellitus, 19 with other autoimmune diseases and 10 controls." | 1.28 | Measurement of thyroid-stimulating immunoglobulins by incorporation of tritiated-adenine into intact FRTL-5 cells: a viable alternative to radioimmunoassay for the measurement of cAMP. ( Colman, PG; Frauman, AG; Leedman, PJ; Michelangeli, VP, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ho, NA | 1 |
| Schmidt, RE | 1 |
| Behrens, G | 1 |
| Takara, M | 1 |
| Kouki, T | 2 |
| DeGroot, LJ | 2 |
| Fukutani, T | 1 |
| Hiromatsu, Y | 1 |
| Kaku, H | 1 |
| Miyake, I | 1 |
| Mukai, T | 1 |
| Imamura, Y | 1 |
| Kohno, S | 1 |
| Takane, N | 1 |
| Shoji, S | 1 |
| Otabe, S | 1 |
| Yamada, K | 1 |
| Sawai, Y | 1 |
| Gardine, CA | 1 |
| Fisfalen, ME | 1 |
| Alegre, ML | 1 |
| Leedman, PJ | 1 |
| Frauman, AG | 1 |
| Colman, PG | 1 |
| Michelangeli, VP | 1 |
| Kendall-Taylor, P | 1 |
6 other studies available for adenine and Graves Disease
| Article | Year |
|---|---|
[HIV-therapy-associated immune reconstitution syndrome presenting as immunogenic hyperthyroidism].
Topics: Adenine; Alkynes; Anti-HIV Agents; Autoantibodies; Benzoxazines; Cyclopropanes; Deoxycytidine; Diagn | 2010 |
CTLA-4 AT-repeat polymorphism reduces the inhibitory function of CTLA-4 in Graves' disease.
Topics: Adenine; Adult; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation; B-Lymphocytes; Case | 2003 |
A polymorphism of interferon-gamma gene associated with changes of anti-thyrotropin receptor antibodies induced by antithyroid drug treatment for Graves' disease in Japanese patients.
Topics: Adenine; Adolescent; Adult; Aged; Aged, 80 and over; Antithyroid Agents; Asian People; Autoantibodie | 2004 |
CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease.
Topics: Abatacept; Adenine; Adjuvants, Immunologic; Alleles; Antibodies, Monoclonal; Antigens, CD; Antigens, | 2000 |
Measurement of thyroid-stimulating immunoglobulins by incorporation of tritiated-adenine into intact FRTL-5 cells: a viable alternative to radioimmunoassay for the measurement of cAMP.
Topics: Adenine; Animals; Autoantibodies; Biological Assay; Cells, Cultured; Cyclic AMP; Epithelium; Graves | 1992 |
Effects of long-acting thyroid stimulator (LATS) and LATS protector on human thyroid adenyl cyclase activity.
Topics: Adenine; Adenosine Monophosphate; Adenylyl Cyclases; Animals; Enzyme Activation; Graves Disease; Hum | 1973 |